Introduction: The Humanoid Robotics Inflection Point

Figure AI has become one of the most explosive private investment opportunities in the artificial intelligence and robotics sectors. The company reached a $39 billion valuation in its Series C funding round in September 2025—a 15x increase from just $2.6 billion 18 months earlier. This remarkable valuation jump reflects investor confidence in Figure's path to commercializing general-purpose humanoid robots at scale.

For accredited investors seeking exposure to one of the defining technologies of the next decade, Figure AI represents a rare opportunity to invest early in a company with substantial institutional backing, real-world deployments, and a multi-trillion-dollar addressable market ahead.

This guide covers everything you need to know about Figure AI: the company's founding story, funding history, investment routes, competitive landscape, and the key risks that accompany pre-revenue robotics ventures.

Figure AI: From Phone Booth Startup to $39B Valuation

Figure AI was founded in May 2022 by Brett Adcock, an entrepreneur with a track record of scaling ambitious hardware and AI ventures. According to Adcock himself, Figure was started in a phone booth in Palo Alto—a fitting metaphor for the company's scrappy origins that belied its lofty ambitions.

Adcock assembled a world-class team by recruiting talent from the industry's most prestigious robotics and AI programs. Figure's founding team includes engineers and researchers from Boston Dynamics, Tesla, Google DeepMind, Apple, and the Florida Institute for Human and Machine Cognition (IHMC). Chief Technology Officer Jerry Pratt, for example, spent two decades at IHMC leading robotics projects before joining Figure. This talent concentration—pulling the best minds from competitors and research institutions—gave Figure an immediate competitive advantage in recruiting and execution.

Figure AI Funding Timeline: The 15x Valuation Jump

Figure's funding trajectory mirrors the explosive growth of the humanoid robotics sector itself:

Round Timing Capital Raised Post-Money Valuation Lead Investor(s)
Seed 2022 $9-10M ~$30-40M Early backers
Series A May 2023 $70M $1.2B Parkway Venture Capital
Series B February 2024 ~$675M $2.6B Microsoft, OpenAI Startup Fund, Bezos Expeditions
Series C September 2025 $1.0B+ $39B Parkway Venture Capital, Brookfield

The 15x valuation increase from Series B to Series C in just 18 months reflects the market's recognition of Figure's technical progress and commercial momentum. No other robotics startup has achieved this velocity.

The Cap Table: Strategic Investors & Industry Giants

Figure's investor base reads like a who's-who of AI, technology, and industrial powerhouses. The company's Series C round exceeded $1 billion in committed capital, with the following major participants:

Investor Type Key Investors Strategic Value
VCs (Primary) Parkway Venture Capital (lead, all rounds), Align Ventures, Tamarack Global Deep robotics expertise, long-term capital
Industrial & Manufacturing Brookfield Asset Management, LG Technology Ventures, Macquarie Capital Real-world deployment opportunities, supply chain access
Semiconductor & Hardware NVIDIA, Intel Capital, Qualcomm Ventures GPU access, chip optimization, manufacturing partnerships
Enterprise & Cloud Salesforce Ventures, Microsoft, Amazon Enterprise deployment, cloud infrastructure, logistics integration
AI Leaders & Billionaires OpenAI Startup Fund, Jeff Bezos (Bezos Expeditions) AI validation, capital, entrepreneurial mentorship
Telecom T-Mobile Ventures 5G connectivity for remote robot operation

This cap table is strategically dense. Rather than pursuing generic venture capital, Figure has attracted investors with specific industrial, manufacturing, and AI expertise. Brookfield's 100,000+ residential units provide a ready deployment market. NVIDIA's involvement signals chip-level optimization for Figure's robotics stack. Microsoft and Amazon offer both capital and deployment opportunities across their vast operations.

Figure 02: The Commercial-Ready Robot

In March 2023, Figure unveiled Figure 01, a commercially viable general-purpose humanoid robot. By 2024-2025, the company had deployed Figure 02—the production-focused evolution—at real manufacturing facilities, including BMW Group Plant Spartanburg.

Figure 02 specifications reflect engineering maturity:

  • Height and dexterity optimized for human-scale manufacturing tasks
  • Hands with 16 degrees of freedom, capable of lifting 55 pounds (25 kg)
  • Each finger contains individual motors and sensors for precise object manipulation
  • Tripled onboard computing and AI power from Figure 01
  • Six RGB cameras with vision-language model for object recognition and hand-eye coordination

At BMW's Spartanburg facility, Figure 02 demonstrated a 400% increase in speed and a sevenfold improvement in success rate during a trial deployment. Over an 11-month trial running daily 10-hour shifts, Figure 02 logged over 1,250 runtime hours and contributed to the production of more than 30,000 X3 vehicles by loading over 90,000 parts into fixtures. This is not a laboratory robot—it's operating on production lines in real time.

The BotQ Manufacturing Facility: Scaling to 12,000+ Units Annually

Capital and engineering talent matter less than manufacturing scale in robotics. Figure recognized this and invested in BotQ, its own manufacturing facility launched in March 2025. BotQ is designed to produce 12,000 humanoid robots annually, eventually scaling to millions.

Vertical integration into manufacturing is crucial: Figure doesn't depend on Foxconn, TSMC, or other third parties to produce its robots. This gives the company control over supply chains, cost curves, and production capacity—assets that competitors like Tesla Optimus are also pursuing but with different supply chain leverage.

Revenue Status: Pre-Revenue Hypothesis

Figure AI remains in pre-revenue or very early revenue stages as of early 2026, despite its $39 billion valuation. The BMW deployment is a pilot, not a massive revenue generator. The company's business model centers on Robot-as-a-Service (RaaS) subscriptions at approximately $1,000 per robot per month, but adoption is still in early stages.

This is the critical tension for investors: Figure is valued as if it's a $39 billion revenue-generating business, but it operates as an early-stage robotics and manufacturing company with massive capital burn and uncertain unit economics. The entire investment thesis depends on:

  • Rapid commercialization of Figure 02 beyond BMW trials
  • Manufacturing cost curves declining as BotQ scales production
  • Customers accepting RaaS models rather than buying robots outright
  • No major technical setbacks or competitive displacement

The company's substantial funding runway ($1.9 billion total raised) buys time for these dynamics to unfold, but execution risk remains extreme.

The Humanoid Robotics Total Addressable Market: $4.85 Trillion by 2035

Understanding Figure's valuation requires understanding the market opportunity it's chasing. Estimates for the humanoid robotics TAM vary widely by research firm and methodology, but all converge on an enormous market:

  • By 2030: Humanoid robot market estimates range from $4 billion to $40 billion depending on the forecasting model. Markets and Markets projects $15.26 billion by 2030 at a 39.2% CAGR. Goldman Sachs estimates $38 billion by 2035.
  • Long-term TAM: The industrial humanoids TAM is roughly $1.75 trillion. Morgan Stanley projects the humanoid robotics market reaching $5 trillion by 2050. Global X ETFs estimates the TAM approaching $4.85 trillion by 2035 across all use cases.

If Figure captures even 1-2% of a $4+ trillion market by 2035-2040, it becomes a company worth hundreds of billions of dollars. That's the bull case—and why $39 billion today doesn't seem insane to investors betting on the humanoid robotics inflection point.

Competitive Landscape: A Multi-Player Market

Figure AI is not alone. The humanoid robotics sector has attracted over 20 active competitors as of 2026, including several well-funded and technologically sophisticated rivals:

Competitor Key Strengths Investment/Partnership
Tesla Optimus Unmatched manufacturing scale, AI integration, Giga factories, $TSLA public currency Internal funding; no external rounds
Boston Dynamics Atlas (Hyundai-backed) Agility, mobility, research pedigree; moving to commercial production at scale Hyundai Motor Group backing; tens of thousands planned
Agility Robotics Digit robot for logistics; Amazon partnership for warehouse automation Amazon strategic investor; multi-year deployment agreements
Sanctuary AI Phoenix robot with human-like dexterity; haptic learning systems Well-funded Canadian startup; enterprise partnerships
1X Technologies NEO robot; humanoid design focused on logistics and service tasks Norsk secured funding; European backing
Other notable players Unitree, Apptronik, Fourier, XPeng, AgiBot, UBTECH, Xiaomi, Boston Engineering Various venture and corporate backing

Tesla Optimus is the obvious competitive threat—a publicly traded company with unlimited manufacturing scale and capital. But Figure's advantages include: (1) specialized focus on humanoid robotics rather than automotive; (2) a deeper team of robotics PhDs; (3) real customer deployments (BMW) ahead of Tesla's public trials; (4) dedicated manufacturing infrastructure (BotQ) designed from the ground up for robots, not cars.

The market is large enough for multiple winners, but Figure must execute flawlessly to remain a top-three player.

How to Invest in Figure AI: The Accredited Investor Path

Figure AI is a private company with no public shares. Unlike **TSLA** (Tesla) or other public robotics-adjacent stocks, direct investment requires accreditation and access to secondary private markets.

Step 1: Verify Accreditation Status

To invest in Figure AI, you must be an accredited investor, defined by the SEC as:

  • Individual with income exceeding $200,000 in each of the last two years (or $300,000+ joint income) with reasonable expectation of same in the current year, OR
  • Individual with net worth exceeding $1 million (excluding primary residence), OR
  • Qualified investor institutions (funds, trusts, etc.)

Step 2: Choose a Secondary Market Platform

Figure AI shares trade on multiple private secondary markets. Popular platforms include:

  • Forge Global (forgeglobal.com): Real-time marketplace with historical trade data and pricing insights. Settlement typically in 45-60 days. Requires identity verification and accreditation proof.
  • EquityZen (equityzen.com): Offers pre-IPO investment through curated secondary offerings and EquityZen funds. Specializes in late-stage private companies.
  • Nasdaq Private Market (nasdaqprivatemarket.com): NASDAQ's private equities marketplace; institutional-grade platform.
  • Notice.co: Simpler interface for secondary trading; emerging platform with growing liquidity.
  • Hiive: Focused on employee and early shareholder liquidity.

Step 3: Understand Terms and Liquidity Constraints

Figure AI maintains transfer restrictions and right-of-first-refusal (ROFR) policies typical of private companies. When you buy Figure shares on secondary markets:

  • The company may exercise ROFR and match or reject the sale
  • Settlement may take 45-60 days as Figure's legal team reviews the transaction
  • Liquidity is limited compared to public markets; bid-ask spreads may be wide
  • You cannot force a liquidity event (IPO or acquisition)—timing depends entirely on Figure's strategic decisions

Step 4: Submit an Offer or Bid

On platforms like Forge:

  • Browse available shares and recent trade prices
  • Submit a bid or respond to an ask
  • Negotiate terms directly with the seller
  • Once agreed, the platform coordinates company approvals and compliance checks
  • Your shares settle into a shareholder agreement and cap table post-close

Pricing and Valuation

Secondary market prices for Figure AI shares reflect the $39 billion Series C valuation but may trade at discounts or premiums depending on:

  • Seller motivation (liquidity needs, tax events, diversification)
  • Buyer interest (demand for exposure to robotics)
  • Recent news and milestones (BMW deployments, BotQ scaling)
  • Broader market sentiment on AI and robotics valuations

Typical current trading ranges on secondary markets reflect post-Series C valuations in the $38-40 billion range, though actual transactions vary by timing and market conditions.

Alternative Routes to Humanoid Robotics Exposure

If direct Figure AI investment is unavailable or too expensive, several alternatives provide exposure to the robotics and AI themes:

  • Public robotics ETFs: Global X Robotics & AI ETF (ticker: **BOTZ**) includes exposure to robotics and automation companies; not Figure-specific but provides sector exposure.
  • Semiconductor leaders: **NVIDIA** and **INTEL** (which both invested in Figure) benefit from humanoid robotics demand for GPUs and AI chips.
  • AI cloud platforms: **MSFT** (Microsoft, Series B investor) provides Azure infrastructure for robotics training and deployment.
  • Logistics and industrial automation: **AMZN** (Amazon, Series B investor) is investing in robotics for warehouse automation; Agility Robotics partnership.
  • Manufacturing leaders: **BMW**, GE, Siemens benefit from robotic automation adoption in their supply chains.
  • Tesla Optimus exposure: **TSLA** (Tesla) is the only publicly traded humanoid robotics developer with unlimited capital and scale.

These public alternatives provide indirect exposure but sacrifice the high-growth, high-risk upside of a pure-play robotics startup.

IPO and Liquidity Timeline

As of March 2026, Figure AI has not announced IPO plans and is unlikely to pursue public markets within the next 2-3 years. The company's $1.9 billion in total funding provides substantial runway for continued private operation, product development, and scaling without immediate liquidity pressure.

Potential liquidity events on the horizon include:

  • Strategic acquisition: A larger tech, automotive, or industrial company could acquire Figure for $50-200 billion+ depending on execution and market conditions.
  • IPO (3-5+ years): Once Figure demonstrates repeatable revenue, profitable unit economics, and market dominance, a public offering becomes plausible.
  • Secondary market trading: Until IPO/acquisition, liquidity flows through secondary markets at variable prices and volumes.

Key Investment Risks

A $39 billion valuation for a pre-revenue robotics startup carries substantial risks that should not be glossed over—a detailed discussion of managing speculative AI positions during valuation swings becomes essential for any investor considering exposure:

Pre-Revenue and Unproven Unit Economics

Figure is valued at $39 billion with near-zero revenue. Profitability and scalable unit economics remain theoretical. The Robot-as-a-Service model at $1,000/month must prove sustainable, but customer acquisition, retention, and manufacturing costs are unproven at scale.

Hardware Manufacturing Execution Risk

Manufacturing humanoid robots at billions of dollars scale is exponentially harder than software. BotQ must ramp production, manage supply chains, ensure quality, and achieve cost reductions. Any manufacturing bottleneck or quality issue could derail commercialization timelines.

Intense Competition

Tesla, Boston Dynamics (Hyundai), Agility Robotics (Amazon), and 20+ other competitors are pursuing the same market. Tesla's manufacturing scale and brand power represent an existential competitive threat. If Optimus achieves product-market fit before Figure 02, the startup's TAM shrinks dramatically.

Regulation and Liability

As humanoid robots enter workplaces and homes, regulation will follow. Worker safety regulations, AI governance frameworks, and liability standards remain unclear. Figure could face unexpected compliance costs or deployment restrictions.

Valuation Sustainability

The 15x valuation jump in 18 months assumes hyperacceleration continues. Any setback—BMW trials disappointing, BotQ production delays, competitive pressure—could trigger a significant valuation reset. Secondary market prices could collapse by 50%+ in a bear scenario.

Lack of Liquidity Event Timeline

Without an IPO or acquisition timeline, your capital is illiquid for years. You cannot easily exit if market sentiment shifts or your financial situation changes.

Data, IP, and Cybersecurity Risks

Figure's robots generate massive amounts of factory data and proprietary manufacturing process information. Cybersecurity breaches, IP theft, or supply chain compromises could damage the company's competitive moat.

The Bull Case for Figure AI

Despite these risks, the bull case is compelling:

  • First-mover with scale: Figure has deployed real robots on production lines ahead of competitors; BotQ provides manufacturing control that many startups lack.
  • Elite team and capital: A $1.9 billion war chest and talent from robotics' best programs gives Figure 3-5 years of runway to achieve product-market fit.
  • Blue-chip validation: Microsoft, Amazon, OpenAI, Jeff Bezos, and NVIDIA believe in Figure's vision enough to deploy capital and strategic partnerships.
  • Massive TAM: A $4+ trillion addressable market dwarfs Figure's current valuation. Even a small percentage capture justifies today's price.
  • Real customer traction: BMW trials prove robots work in real environments. This transcends the "science project" narrative plaguing other robotics startups.
  • Inflection point dynamics: Humanoid robotics may be entering a hockey-stick adoption curve. Figure's technical and operational lead could compound over years.

The Bear Case for Figure AI

The risks are equally compelling:

  • Pre-revenue valuation is speculative: At $39 billion with zero revenue, the company is priced for perfection. Any stumble could halve the valuation.
  • Tesla will likely win: Optimus has unlimited capital, manufacturing scale, and AI expertise. Figure may be a rounding error in Tesla's robotics roadmap by 2030.
  • Hardware is harder than software: Robotics companies have a notoriously poor success rate. Even well-funded startups fail to achieve commercial scale.
  • Manufacturing at scale is unproven: BotQ's ability to produce 12,000 units annually and reduce costs to profitability is entirely speculative.
  • Liquidity could evaporate: If sentiment shifts, secondary market trading could dry up, trapping capital for years.
  • No IPO timeline: You may wait 5-10+ years for a liquidity event, unable to exit even if you want to.

Conclusion: A High-Risk, High-Reward Opportunity

Figure AI represents a rare opportunity to invest early in a potential foundational technology platform. The company has demonstrated more technical and commercial progress than any other humanoid robotics startup, has attracted world-class investors and talent, and is operating in a market that could reach trillions of dollars.

However, the $39 billion valuation is not conservative. It assumes flawless execution, sustained competitive advantages, and rapid commercialization in an industry where hardware failures are common. The risks are real and concentrated: pre-revenue status, manufacturing execution, intense competition from Tesla and others, and uncertain liquidity timelines.

For accredited investors with high risk tolerance and a 5-10 year investment horizon, Figure AI offers compelling exposure to the humanoid robotics inflection point. For conservative investors or those seeking near-term liquidity, the risks likely outweigh the potential returns.

The key to evaluating this investment is acknowledging that you are betting not just on Figure AI as a company, but on humanoid robotics as a transformational technology category. If you believe that belief, Figure AI is one of the purest plays available today.

Also in this series: How to Invest in OpenAI | How to Invest in Anthropic

Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. Frontier Ledger is not a registered investment advisor. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult a qualified financial professional before making investment decisions.